ORs for the outcome lack of DVT resolution
| Predictor . | Univariable analysis OR (95% CI) . | P . |
|---|---|---|
| Group | ||
| Non-LR vs LRnon-neonates | 1.75 (0.84-3.63) | .28 |
| LRneonates vs LRnon-neonates | 0.96 (0.56-1.64) | |
| Treatment | ||
| None/prophylaxis vs thrombolysis | 0.22 (0.04-1.23) | .21 |
| Anticoagulants vs thrombolysis | 0.29 (0.07-1.26) | |
| Age at the time of LE-DVT, y | 1.01 (0.97-1.06) | .54 |
| Sex (male vs female) | 0.68 (0.41-1.07) | .09 |
| Number of affected venous segments | 1.57 (1.25-1.99) | <.001 |
| At least 1 occlusive segment at DVT diagnosis (yes vs no) | 9.25 (5.04-16.98) | <.001 |
| Thrombophilia | ||
| None vs major | 0.96 (0.39-2.39) | .70 |
| Minor vs major | 0.69 (0.23-2.09) | |
| DVT level (femoro-popliteal vs ilio-femoral) | 1.65 (0.62-4.38) | .32 |
| Predictor | Multivariable analysis OR (95% CI) | P |
| Omnibus likelihood ratio | <.001 | |
| At least 1 occlusive segment at DVT diagnosis (yes vs no) | 9.25 (5.04-16.98) | <.001 |
| Predictor . | Univariable analysis OR (95% CI) . | P . |
|---|---|---|
| Group | ||
| Non-LR vs LRnon-neonates | 1.75 (0.84-3.63) | .28 |
| LRneonates vs LRnon-neonates | 0.96 (0.56-1.64) | |
| Treatment | ||
| None/prophylaxis vs thrombolysis | 0.22 (0.04-1.23) | .21 |
| Anticoagulants vs thrombolysis | 0.29 (0.07-1.26) | |
| Age at the time of LE-DVT, y | 1.01 (0.97-1.06) | .54 |
| Sex (male vs female) | 0.68 (0.41-1.07) | .09 |
| Number of affected venous segments | 1.57 (1.25-1.99) | <.001 |
| At least 1 occlusive segment at DVT diagnosis (yes vs no) | 9.25 (5.04-16.98) | <.001 |
| Thrombophilia | ||
| None vs major | 0.96 (0.39-2.39) | .70 |
| Minor vs major | 0.69 (0.23-2.09) | |
| DVT level (femoro-popliteal vs ilio-femoral) | 1.65 (0.62-4.38) | .32 |
| Predictor | Multivariable analysis OR (95% CI) | P |
| Omnibus likelihood ratio | <.001 | |
| At least 1 occlusive segment at DVT diagnosis (yes vs no) | 9.25 (5.04-16.98) | <.001 |